Oligonucleotide ligation assay: applications to molecular diagnosis of inherited disorders

REFERENCES

• Wagener C, Epplen JT, Erlich H, Peretz H, Vihko P. Molecular biology techniques in the diagnosis of monogenic diseases. Clin Chim Acta 1994; 225: S35 — 50.
   Google Scholar
• Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science 1988; 241: 1077–80.
   PubMed Web of Science ®Google Scholar
• Nickerson DA, Kaiser R, Lappin S, Stewart J, Hood L, Landegren U. Automated DNA diag-nostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A 1990; 87: 8923–7.
   PubMed Web of Science ®Google Scholar
• Grossman PD, Bloch W, Brinson E, Chang CC, Eggerding FA, Fung S, et al. High-density multi-plex detection of nucleic acid sequences: oligo-nucleotide ligation assay and sequence-coded separation. Nucleic Acids Res 1994; 22: 4527–34.
   PubMed Web of Science ®Google Scholar
• Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, et al. Mutations in the palmitoyl protein thioesterase gene causing infan-tile neuronal ceroid lipofuscinosis. Nature 1995; 376: 584–7.
   PubMed Web of Science ®Google Scholar
• Kestild M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syn-drome. Mol Cell 1998; 1: 575–82.
   Google Scholar
• Romppanen E-L, Valtonen P, Mononen T, Mononen I. Molecular diagnosis of Finnish type infantile neuronal ceroid lipofuscinosis by restric-tion fragment length polymorphism and oligo-nucleotide ligation assay. Clin Chem 1998; 44: 2373–6.
   Google Scholar
• Romppanen E-L, Mononen I. Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment length polymorphism and dual-color oligonucleotide ligation assay. Clin Chem 2000; 46: 811–16.
   Google Scholar
• Santavuori P, Vanhanen S-L, Sainio K, Nieminen M, Wallden T, Launes J, Raininko R. Infantile neuronal ceroid-lipofuscinosis (INCL): Diagnostic criteria. J Inher Metab Dis 1993; 16: 227–9.
   Google Scholar
• Das AK, Becerra CHR, Yi W, Lu J-Y, Siakotos AN, Wisniewski KE. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 1998; 102: 361–70.
   PubMed Web of Science ®Google Scholar
• Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 1995; 9: 87–93.
   PubMed Web of Science ®Google Scholar
• Huttunen N-P. Congenital nephrotic syndrome of Finnish type. Arch Dis Child 1976; 51: 344–8.
   PubMed Web of Science ®Google Scholar
• Matsubara Y, Narisawa K, Miyabayashi S, Tada K, Coates PM, Bachmann C, et al. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Biochem Biophys Res Commun 1990; 171: 498–505.
   PubMed Web of Science ®Google Scholar
• Romppanen E-L, Mononen T, Mononen I. Molecular diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by oligonucleotide ligation assay. Clin Chem 1998; 44: 68–71.
   Google Scholar
• Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995: 1501–33.
   Google Scholar
• Matsubara Y, Narisawa K, Tada K, Ikeda H, Ye-Qi Y, Danks DM, et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogen-ase gene determined from Guthrie cards [Letter]. Lancet 1991; 338: 552–3.
   Google Scholar
• Ziadeh R, Hoffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW, Naylor EW. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 1995; 37: 675–8.
   Google Scholar
• Seddon HR, Gray G, Pollitt RJ, Iitiä A, Green A. Population screening for the common G985 mutation causing medium-chain acyl-CoA dehy-drogenase deficiency with Eu-labeled oligonucleo-tides and the DELFIA system. Clin Chem 1997; 43: 436 — 42.
   Google Scholar
• Romppanen E-L, Mononen I. PCR-oligonucleotide ligation assay from dried blood spots. Clin Chem 1999; 45: 2022–5.
   Google Scholar
• Delahunty CM, Ankener W, Brainerd S, Nickerson DA, Mononen TT. Finnish-type aspar-tylglucosaminuria detected by oligonucleotide ligation assay. Clin Chem 1995; 41: 59–61.
   Google Scholar
• Mononen T, Mononen I, Matilainen R, Airaksinen E. High prevalence of aspartylglyco-saminuria among school-age children in Eastern Finland. Hum Genet 1991; 87: 266–8.
   Google Scholar
• Santavuori P, Haltia M, Rapola J. Infantile type of so-called neuronal ceroid-lipofuscinosis. Develop Med Child Neurol 1974; 16: 644–53.
   PubMed Web of Science ®Google Scholar
• Uvebrandt P, Hagberg B. Neuronal ceroid lipo-fuscinosis in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics 1997; 28: 6–8.
   Google Scholar
• Schwartz El, Ilonen J, Skobeleva NA, Akerblom HK. The frequency of MCAD mutation (K329E) in the Finnish population. Eur J Pediatr 1995; 154: 501.
   Google Scholar
• Landegren U, Kaiser R, Caskey CT, Hood LE. DNA diagnostics-molecular techniques and auto-mation. Science 1988; 242: 229–37.
   PubMed Web of Science ®Google Scholar
• Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A 1991; 88: 189–93.
   PubMed Web of Science ®Google Scholar
• Hansen TS, Petersen NE, Iitiä A, Blaabjerg 0, Hyltoft-Petersen P, Harder M. Robust nonradio-active oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism. Clin Chem 1995; 41: 413–18.
   Google Scholar
• Zotz RB, Giers G, Maruhn-Debowski B, Scharf RE. Genetic typing of human platelet antigen 1 (HPA-1) by oligonucleotide ligation assay in a specific and reliable semi-automated system. Br J Haematol 1997; 96: 198–203.
   Google Scholar